The overlap of small molecule and protein binding sites within families of protein structures

PLoS Computational Biology

Volumn 6, Issue 2, 2010, Pages

  Davis, Fred P ^a   Sali, Andrej ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BINDING SITES; DISEASES; MOLECULES; PROTEINS;

LIGAND-BINDING SITES; PROTEIN COMPLEXES; PROTEIN INTERACTION; PROTEIN-BINDING SITES; PROTEIN-PROTEIN INTERACTIONS; PROTEINS STRUCTURES; SMALL MOLECULES; SMALL PROTEINS; SMALL-MOLECULE BINDINGS; TARGET PROTEINS;

LIGANDS;

BEPRIDIL; FUSICOCCIN; LIGAND; SANGLIFEHRIN A; TRYPTOPHAN; TYROSINE; PROTEIN;

ARTICLE; BINDING SITE; LIGAND BINDING; MOLECULE; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; VIRION; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; NONPARAMETRIC TEST; PROTEIN DOMAIN;

VERTEBRATA;

BINDING SITES; COMPUTATIONAL BIOLOGY; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 77649228104     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000668     Document Type: Article

References (54)

1. Berg T (2003) Modulation of protein-protein interactions with small organic molecules. Angew Chem Int Ed Engl 42: 2462-2481.
2. Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009.
3. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3: 301-317.
4. Jones S, Thornton JM (1996) Principles of protein-protein interactions. Proc Natl Acad Sci U S A 93: 13-20.
5. Conte LL, Chothia C, Janin J (1999) The atomic structure of protein-protein recognition sites. J Mol Biol 285: 2177-2198.
6. Caffrey DR, Somaroo S, Hughes JD, Mintseris J, Huang ES (2004) Are protein-protein interfaces more conserved in sequence than the rest of the protein surface? Protein Sci 13: 190-202.
7. Laskowski RA, Luscombe NM, Swindells MB, Thornton JM (1996) Protein clefts in molecular recognition and function. Protein Sci 5: 2438-2452.
8. Clackson T, Wells JA (1995) A hot spot of binding energy in a hormone-receptor interface. Science 267: 383-386.
9. Bogan AA, Thorn KS (1998) Anatomy of hot spots in protein interfaces. J Mol Biol 280: 1-9.
10. Keskin O, Ma B, Nussinov R (2005) Hot regions in protein-protein interactions: the organization and contribution of structurally conserved hot spot residues. J Mol Biol 345: 1281-1294.
11. Thanos CD, DeLano WL, Wells JA (2006) Hot-spot mimicry of a cytokine receptor by a small molecule. Proc Natl Acad Sci U S A 103: 15422-15427.
12. Arkin MR, Randal M, DeLano WL, Hyde J, Luong TN, et al. (2003) Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A 100: 1603-1608.
13. Eyrisch S, Helms V (2007) Transient pockets on protein surfaces involved in protein-protein interaction. J Med Chem 50: 3457-3464.
14. Elber R, Karplus M (1987) Multiple conformational states of proteins: a molecular dynamics analysis of myoglobin. Science 235: 318-321.
15. Qian B, Ortiz AR, Baker D (2004) Improvement of comparative model accuracy by free-energy optimization along principal components of natural structural variation. Proc Natl Acad Sci U S A 101: 15346-15351.
16. Leo-Macias A, Lopez-Romero P, Lupyan D, Zerbino D, Ortiz AR (2005) An analysis of core deformations in protein superfamilies. Biophys J 88: 1291-1299.
17. Davis FP, Sali A (2005) Pibase: a comprehensive database of structurally defined protein interfaces. Bioinformatics 21: 1901-1907.
18. Murzin AG, Brenner SE, Hubbard T, Chothia C (1995) Scop: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol 247: 536-540.
19. Stuart AC, Ilyin VA, Sali A (2002) Ligbase: a database of families of aligned ligand binding sites in known protein sequences and structures. Bioinformatics 18: 200-201.
20. Chandonia JM, Hon G, Walker NS, Conte LL, Koehl P, et al. (2004) The astral compendium in 2004. Nucleic Acids Res 32: D189-D192.
21. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
22. Wilson D, Pethica R, Zhou Y, Talbot C, Vogel C, et al. (2009) Superfamily-sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic Acids Res 37: D380-D386.
23. Ellis JJ, Broom M, Jones S (2007) Protein-rna interactions: structural analysis and functional classes. Proteins 66: 903-911.
24. Erlanson DA, Wells JA, Braisted AC (2004) Tethering: fragment-based drug discovery. Annu Rev Biophys Biomol Struct 33: 199-223.
25. Marti-Renom MA, Rossi A, Al-Shahrour F, Davis FP, Pieper U, et al. (2007) The annolite and annolyze programs for comparative annotation of protein structures. BMC Bioinformatics 8 Suppl 4: S4.
26. Crabtree GR, Schreiber SL (1996) Three-part inventions: intracellular signaling and induced proximity. Trends Biochem Sci 21: 418-422.
27. Bhattacharyya RP, Remenyi A, Yeh BJ, Lim WA (2006) Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu Rev Biochem 75: 655-680.
28. Sokolskaja E, Sayah DM, Luban J (2004) Target cell cyclophilin a modulates human immunodeficiency virus type 1 infectivity. J Virol 78: 12800-12808.
29. Sedrani R, Kallen J, Cabrejas LMM, Papageorgiou CD, Senia F, et al. (2003) Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, x-ray crystal structure, and binding data. J Am Chem Soc 125: 3849-3859.
30. Howard BR, Vajdos FF, Li S, Sundquist WI, Hill CP (2003) Structural insights into the catalytic mechanism of cyclophilin a. Nat Struct Biol 10: 475-481.
31. Wurtele M, Jelich-Ottmann C, Wittinghofer A, Oecking C (2003) Structural view of a fungal toxin acting on a 14-3-3 regulatory complex. EMBO J 22: 987-994.
32. Bunney TD, Boer AHD, Levin M (2003) Fusicoccin signaling reveals 14-3-3 protein function as a novel step in left-right patterning during amphibian embryogenesis. Development 130: 4847-4858.
33. Sanchez AM, Thomas D, Gillespie EJ, Damoiseaux R, Rogers J, et al. (2007) Amiodarone and bepridil inhibit anthrax toxin entry into host cells. Antimicrob Agents Chemother 51: 2403-2411.
34. Wang X, Li MX, Sykes BD (2002) Structure of the regulatory n-domain of human cardiac troponin c in complex with human cardiac troponin i147-163 and bepridil. J Biol Chem 277: 31124-31133.
35. Drum CL, Yan SZ, Bard J, Shen YQ, Lu D, et al. (2002) Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415: 396-402.
36. Higueruelo AP, Schreyer A, Bickerton GR, Pitt WR, Groom CR, et al. (2009) Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the timbal database. Chem Biol Drug Des 74: 457-467.
37. Parthasarathi L, Casey F, Stein A, Aloy P, Shields DC (2008) Approved drug mimics of short peptide ligands from protein interaction motifs. J Chem Inf Model 48: 1943-1948.
38. Kleywegt GJ (1999) Recognition of spatial motifs in protein structures. J Mol Biol 285: 1887-1897.
39. Zhu H, Sommer I, Lengauer T, Domingues FS (2008) Alignment of noncovalent interactions at protein-protein interfaces. PLoS ONE 3: e1926.
40. Shulman-Peleg A, Shatsky M, Nussinov R, Wolfson HJ (2008) Multibind and mappis: webservers for multiple alignment of protein 3d-binding sites and their interactions. Nucleic Acids Res 36: W260-W264.
41. Ofran Y, Rost B (2007) Protein-protein interaction hotspots carved into sequences. PLoS Comput Biol 3: e119.
42. Thorn KS, Bogan AA (2001) Asedb: a database of alanine mutations and their effects on the free energy of binding in protein interactions. Bioinformatics 17: 284-285.
43. Kortemme T, Baker D (2002) A simple physical model for binding energy hot spots in protein-protein complexes. Proc Natl Acad Sci U S A 99: 14116-14121.
44. Ma B, Elkayam T, Wolfson H, Nussinov R (2003) Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces. Proc Natl Acad Sci U S A 100: 5772-5777.
45. Kuriyan J, Eisenberg D (2007) The origin of protein interactions and allostery in colocalization. Nature 450: 983-990.
46. Datta D, Scheer JM, Romanowski MJ, Wells JA (2008) An allosteric circuit in caspase-1. J Mol Biol 381: 1157-1167.
47. Collins SR, Kemmeren P, Zhao XC, Greenblatt JF, Spencer F, et al. (2007) Toward a comprehensive atlas of the physical interactome of saccharomyces cerevisiae. Mol Cell Proteomics 6: 439-450.
48. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for hiv infection through a functional genomic screen. Science 319: 921-926.
49. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, et al. (2008) Hepatitis c virus infection protein network. Mol Syst Biol 4: 230.
50. Davis FP, Barkan DT, Eswar N, McKerrow JH, Sali A (2007) Host pathogen protein interactions predicted by comparative modeling. Protein Sci 16: 2585-2596.
51. Dyer MD, Murali TM, Sobral BW (2008) The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog 4: e32.
52. Projan SJ (2003) Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 6: 427-430.
53. Lebeis SL, Kalman D (2009) Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions. Cell Host Microbe 5: 114-122.
54. Dimitropoulos D, Ionides J, Henrick K (2006) Using msdchem to search the pdb ligand dictionary. Curr Protoc Bioinformatics Chapter 14: Unit14.3.